Split daily recombinant human LH dose in hypogonadotrophic hypogonadism: A nonrandomized controlled pilot study

Reproductive BioMedicine Online

Volumn 26, Issue 1, 2013, Pages 88-92

  Awwad, Johnny T ^a   Farra, Chantal ^a   Mitri, Frederic ^a   Abdallah, Michel Abou ^a   Jaoudeh, Mona Abou ^a,b   Ghazeeri, Ghina ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b RIZK HOSPITAL   (Lebanon)

Author keywords

Follicles; Gonadotrophins; Hypogonadotrophic hypogonadism; Ovulation; Recombinant human LH; Split dose

Indexed keywords

ESTRADIOL; PROGESTERONE; RECOMBINANT FOLLITROPIN; RECOMBINANT LUTEINIZING HORMONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; ENDOMETRIAL THICKNESS; ESTRADIOL BLOOD LEVEL; FEMALE; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; OVARY FOLLICLE DEVELOPMENT; OVARY HYPERSTIMULATION; OVULATION; PROGESTERONE BLOOD LEVEL; SINGLE DRUG DOSE; TREATMENT OUTCOME;

EID: 84874118421     PISSN: 14726483     EISSN: 14726491     Source Type: Journal    
DOI: 10.1016/j.rbmo.2012.09.016     Document Type: Article

References (20)

1. Balasch, J., Fabregues, F., Carmona, F., Casamitjana, R., Tena-Sempere, M., 2009. Ovarian luteinizing hormone priming preceding follicle-stimulating hormone stimulation: clinical and endocrine effects in women with long-term hypogonadotropic hypogonadism. J. Clin. Endocrinol. Metab. 94, 2367-2373.
2. Balen, A.H., Braat, D.D., West, C., Patel, A., Jacobs, H.S., 1994. Cumulative conception and live birth rates after the treatment of anovulatory infertility: safety and efficacy of ovulation induction in 200 patients. Hum. Reprod. 9, 1563-1570.
3. Burgues, S., 2001. The effectiveness and safety of recombinant human LH to support follicular development induced by recombinant human FSH in WHO group I anovulation: evidence from a multicentre study in Spain. Hum. Reprod. 16, 2525-2532.
4. Daya, S., Gunby, J., Hughes, E.G., Collins, J.A., Sagle, M.A., 1995. Follicle-stimulating hormone versus human menopausal gonadotropin for in vitro fertilization cycles: a meta-analysis. Fertil. Steril. 64, 347-354.
5. de Leo, V., Musacchio, M.C., di Sabatino, A., Tosti, C., Morgante, G., Petraglia, F., 2012. Present and future of recombinant gonadotropins in reproductive medicine. Curr. Pharm. Biotechnol. 13, 379-391.
6. European Recombinant Human LH Study Group, 1998. Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH-and FSH-deficient anovulatory women: a dose-finding study. J. Clin. Endocrinol. Metab. 83, 1507-1514.
7. Franco Jr., J.G., Baruffi, R.L., Oliveira, J.B., Mauri, A.L., Petersen, C.G., Contart, P., Felipe, V., 2009. Effects of recombinant LH supplementation to recombinant FSH during induced ovarian stimulation in the GnRH-agonist protocol: a matched case-control study. Reprod. Biol. Endocrinol. 7, 58.
8. Gibreel, A., Bhattacharya, S., 2010. Recombinant follitropin alfa/lutropin alfa in fertility treatment. Biologics 4, 5-17.
9. Gordon, U.D., Harrison, R.F., Fawzy, M., Hennelly, B., Gordon, A.C., 2001. A randomized prospective assessor-blind evaluation of luteinizing hormone dosage and in vitro fertilization outcome. Fertil. Steril. 75, 324-331.
10. Howles, C.M., 2000. Role of LH and FSH in ovarian function. Mol. Cell. Endocrinol. 161, 25-30.
11. Kaufmann, R., Dunn, R., Vaughn, T., Hughes, G., O'Brien, F., Hemsey, G., Thomson, B., O'Dea, L.S., 2007. Recombinant human luteinizing hormone, lutropin alfa, for the induction of follicular development and pregnancy in profoundly gonadotrophin-deficient women. Clin. Endocrinol. (Oxf.) 67, 563-569.
12. Krause, B.T., Ohlinger, R., Haase, A., 2009. Lutropin alpha, recombinant human luteinizing hormone, for the stimulation of follicular development in profoundly LH-deficient hypogonadotropic hypogonadal women: a review. Biologics 3, 337-347.
13. le Cotonnec, J.Y., Loumaye, E., Porchet, H.C., Beltrami, V., Munafo, A., 1998. Pharmacokinetic and pharmacodynamic interactions between recombinant human luteinizing hormone and recombinant human follicle-stimulating hormone. Fertil. Steril. 69, 201-209.
14. Martin, K.A., Hall, J.E., Adams, J.M., Crowley Jr., W.F., 1993. Comparison of exogenous gonadotropins and pulsatile gonadotropin-releasing hormone for induction of ovulation in hypogonadotropic amenorrhea. J. Clin. Endocrinol. Metab. 77, 125-129.
15. Schoot, D.C., Harlin, J., Shoham, Z., Mannaerts, B.M., Lahlou, N., Bouchard, P., Bennink, H.J., Fauser, B.C., 1994. Recombinant human follicle-stimulating hormone and ovarian response in gonadotrophin-deficient women. Hum. Reprod. 9, 1237-1242.
16. Shapiro, H., Cowell, C., Casper, R.F., 1993. The use of vaginal ultrasound for monitoring endometrial preparation in a donor oocyte program. Fertil. Steril. 59, 1055-1058.
17. Shoham, Z., Balen, A., Patel, A., Jacobs, H.S., 1991. Results of ovulation induction using human menopausal gonadotropin or purified follicle-stimulating hormone in hypogonadotropic hypogonadism patients. Fertil. Steril. 56, 1048-1053.
18. Shoham, Z., Smith, H., Yeko, T., O'Brien, F., Hemsey, G., O'Dea, L., 2008. Recombinant LH (lutropin alfa) for the treatment of hypogonadotrophic women with profound LH deficiency: a randomized, double-blind, placebo-controlled, proof-of-efficacy study. Clin. Endocrinol. (Oxf.) 69, 471-478.
19. Tarlatzis, B., Tavmergen, E., Szamatowicz, M., Barash, A., Amit, A., Levitas, E., Shoham, Z., 2006. The use of recombinant human LH (lutropin alfa) in the late stimulation phase of assisted reproduction cycles: a double-blind, randomized, prospective study. Hum. Reprod. 21, 90-94.
20. Weghofer, A., Munne, S., Brannath, W., Chen, S., Tomkin, G., Cekleniak, N., Garrisi, M., Barad, D., Cohen, J., Gleicher, N., 2008. The impact of LH-containing gonadotropins on diploidy rates in preimplantation embryos: long protocol stimulation. Hum. Reprod. 23, 499-503.